Seeking Alpha

The FDA is expanding the approved use of Abbott's (ABT -1%) Humira to include treatment of...

The FDA is expanding the approved use of Abbott's (ABT -1%) Humira to include treatment of moderate-to-severe ulcerative colitis in adults, when immunosuppressant medicines have not worked. The drug is currently approved for use in reducing the signs and symptoms of rheumatoid arthritis.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs